Craik CS - Search Results

1

Structural basis of prostaglandin efflux by MRP4.

Pourmal S, Green E, Bajaj R, Chemmama IE, Knudsen GM, Gupta M, Sali A, Cheng Y, Craik CS, Kroetz DL, Stroud RM. Pourmal S, et al. Among authors: craik cs. Nat Struct Mol Biol. 2024 Apr;31(4):621-632. doi: 10.1038/s41594-023-01176-4. Epub 2024 Jan 12. Nat Struct Mol Biol. 2024. PMID: 38216659 Free PMC article.

2

1.59 A structure of trypsin at 120 K: comparison of low temperature and room temperature structures.

Earnest T, Fauman E, Craik CS, Stroud R. Earnest T, et al. Among authors: craik cs. Proteins. 1991;10(3):171-87. doi: 10.1002/prot.340100303. Proteins. 1991. PMID: 1881877

3

Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor.

Rose RB, Rosé JR, Salto R, Craik CS, Stroud RM. Rose RB, et al. Among authors: craik cs. Biochemistry. 1993 Nov 23;32(46):12498-507. doi: 10.1021/bi00097a030. Biochemistry. 1993. PMID: 8241141

4

Three-dimensional structures of HIV-1 and SIV protease product complexes.

Rose RB, Craik CS, Douglas NL, Stroud RM. Rose RB, et al. Among authors: craik cs. Biochemistry. 1996 Oct 1;35(39):12933-44. doi: 10.1021/bi9612733. Biochemistry. 1996. PMID: 8841139

5

A new class of HIV-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere.

Rutenber EE, McPhee F, Kaplan AP, Gallion SL, Hogan JC Jr, Craik CS, Stroud RM. Rutenber EE, et al. Among authors: craik cs. Bioorg Med Chem. 1996 Sep;4(9):1545-58. doi: 10.1016/0968-0896(96)00147-2. Bioorg Med Chem. 1996. PMID: 8894111

6

The discovery, characterization and crystallographically determined binding mode of an FMOC-containing inhibitor of HIV-1 protease.

Rutenber EE, De Voss JJ, Hoffman L, Stroud RM, Lee KH, Alvarez J, McPhee F, Craik C, Ortiz de Montellano PR. Rutenber EE, et al. Bioorg Med Chem. 1997 Jul;5(7):1311-20. doi: 10.1016/s0968-0896(97)00078-3. Bioorg Med Chem. 1997. PMID: 9377091

7

Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.

Rose RB, Craik CS, Stroud RM. Rose RB, et al. Among authors: craik cs. Biochemistry. 1998 Feb 24;37(8):2607-21. doi: 10.1021/bi9716074. Biochemistry. 1998. PMID: 9485411

8

Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.

Reiling KK, Pray TR, Craik CS, Stroud RM. Reiling KK, et al. Among authors: craik cs. Biochemistry. 2000 Oct 24;39(42):12796-803. doi: 10.1021/bi001019h. Biochemistry. 2000. PMID: 11041844

9

Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure.

Reiling KK, Endres NF, Dauber DS, Craik CS, Stroud RM. Reiling KK, et al. Among authors: craik cs. Biochemistry. 2002 Apr 9;41(14):4582-94. doi: 10.1021/bi011781z. Biochemistry. 2002. PMID: 11926820

10

Prediction of protease substrates using sequence and structure features.

Barkan DT, Hostetter DR, Mahrus S, Pieper U, Wells JA, Craik CS, Sali A. Barkan DT, et al. Among authors: craik cs. Bioinformatics. 2010 Jul 15;26(14):1714-22. doi: 10.1093/bioinformatics/btq267. Epub 2010 May 26. Bioinformatics. 2010. PMID: 20505003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters